The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …

Rheumatoid arthritis (RA) is a chronic, debilitating disease that significantly impacts patients'
quality of life and socioeconomic productivity. On a personal level, RA has a significant …

Objective The study objective was to evaluate and update the safety data from randomized
controlled trials of tumor necrosis factor inhibitors in patients treated for rheumatoid arthritis …

Health-related quality of life (HR-QOL) in patients with rheumatoid arthritis (RA) is
significantly impaired as a result of pain, deficits in physical function and fatigue associated …

This study reviewed the effect of biological agents on participation in paid work among
patients with rheumatoid arthritis (RA). A systematic literature search was performed to …

Objective. To describe working status in patients with RA, AS and PsA treated with anti-TNF
therapy registered with the British Society for Rheumatology Biologics Register. Methods …

Objectives. To compare the impact of the combination of etanercept (ETN) and MTX with
MTX alone on work productivity among MTX-naïve patients with active early RA over a 12 …

Objective To evaluate household and work place outcomes for patients with rheumatoid
arthritis (RA) who were homemakers or employed workers, respectively, and who were …

Patients with established rheumatoid arthritis (RA) may incur important resource utilisation
and work productivity loss, resulting in high costs of illness. Impairment in physical function …

Background Patients with rheumatoid arthritis (RA) have difficulties maintaining employment
due to the impact of the disease on their work ability. This review aims to investigate the …